Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 10
Submit an article Journal homepage
8
Views
1
CrossRef citations to date
0
Altmetric
Research

Company Profile Sankyo: analysis of patenting 1993 – 1996

Peter Steele Intellectual Property Consultancy, Suite 18, Roman House, 9–10 College Terrace, London, E3 5AN, UK
Pages 955-965 | Published online: 29 Feb 2008

References

  • STEELE P: Abbott: analysis of patenting 1989-1993. Exp. Opin. Ther. Patents (1994) 4(2):99–108.
  • STEELE P: American Home Products Corp. (AHP): analy-sis of patenting 1989–1993. R. Opin. Ther. Patents(1994) 4(3):207–215.
  • STEELE P: SmithKline Beecham: analysis of patenting 1989-1993. Exp. Opin. Ther. Patents (1994) 4(4):303–313.
  • STEELE P: Glaito: analysis of patenting 1989-1993. Exp. Opin. Ther. Patents (1994) 4(5):479–487.
  • STEELE P: Takeda: analysis of patenting 1989-1994. Exp. Opin. Ther. Patents (1994) 4(6):611–619.
  • STEELE P: Rhilne-Poulenc Rorer: analysis of patenting 1989-1994. Exp. Opin. Ther. Patents (1994) 4(7):751–760.
  • STEELE P: Schering Plough: analysis of patenting 1989–1994. Exp. Opin. Ther. Patents (1994) 4(8)903–910.
  • STEELE P: Amgen, Inc.: analysis of patenting 1989–1994. Exp. Opin. Ther. Patents (1994) 4(9):1029–1035.
  • STEELE P: Merck & Co., Inc.: analysis of patenting 1991–1994. Exp. Opin. Ther. Patents (1994) 4(10):1161–1172.
  • STEELE P: Hoechst analysis of patenting 1991-1994. Exp. Opin. Ther. Patents (1994) 4(11):1309–1318.
  • STEELE P: F Hoffmann-La Roche Ltd.: analysis of patent-ing 1991–1994. Exp. Opin. Ther. Patents (1994) 4(12):1437–1444.
  • STEELE P: Bayer: analysis of patenting 1991-1994. Exp. Opin. Ther. Patents (1995) 5(1):1–11.
  • STEELE P: Pfizer, Inc.: analysis of patenting 1989–1994. Exp. Opin. Ther. Patents (1995) 5(2):99–110.
  • STEELE P: Wellcome analysis of patenting 1991–1995. Exp. Opin. Ther. Patents (1995) 5(3)191–198.
  • STEELE P: Johnson & Johnson: analysis of patenting 1991–1995. Exp. Opin. Ther. Patents (1995) 5(3)199–210.
  • STEELE P: Zeneca: analysis of patenting 1991–1995. Exp. Opin. Ther. Patents (1995) 5(4)277–285.
  • STEELE P: Ciba-Geigy: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(5):381–389.
  • STEELE P: Bristol-Myers Squibb: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(6):517–528.
  • STEELE P: Yamanouchi: analysis of patenting 1989-1995. Exp. Opin. Ther. Patents (1995) 5(7):611–622.
  • STEELE P: Sandoz: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(8):735–745.
  • STEELE P: Eli Lilly: analysis of patenting 1991-1995. Esp. Opin. Ther. Patents (1995) 5(9):861–871.
  • STEELE P: Warner-Lambert analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(10):1015–1025.
  • STEELE P: Pharmacia: analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1995) 5(11)1147–1154.
  • STEELE P: Upjohn analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1995) 5(11)1155–1161.
  • STEELE P: Sanofi: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(12):1259–1267.
  • STEELE P: Boehringer Ingelheim: analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1996) 6(1)1–9.
  • STEELE P: National Institutes of Health: analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1996) 6(2)117–128.
  • STEELE P: Fujisawm analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1996) 6(3)229–238.
  • STEELE P: Chiron: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1996) 6(4):303–312.
  • STEELE P: Schering AG: analysis of patenting 1992–1995. Exp. Opin. Ther. Patents (1996) 6(5)431–439.
  • STEELE P: Astra: analysis of patenting 1993-1996. Exp. Opin. Ther. Patents (1996) 6(6):535–542.
  • STEELE P: Monsanto: analysis of patenting 1993-1996. Exp, Opin. Ther. Patents (1996) 6(7):611–617.
  • STEELE P: British Technology Group: analysis of patent-ing 1993–1996. Exp. Opin. Ther. Patents (1996) 6(8)703–709.
  • STEELE P: Merck KGaA: analysis of patenting 1993-1996. Exp. Opin. Ther. Patents (1996) 6(9):837–844.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.